Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Medicine|August 24, 2017
C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysisJing Li, Xuedan Jiao, Zhongfu Yuan, et al.Cell Cycle (Georgetown, Tex.)|June 12, 2018
Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with PaclitaxelHaifeng Qiu, Jing Li, Qiuli Liu, et al.Asian Pacific Journal of Cancer Prevention : APJCP|June 2, 2011
SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activatedHaifeng Qiu, Jiezhi Zhu, Jinjin Yu, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 5, 2012
Platelet-derived growth factor-D promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9Yuan Wang, Chaoying Hu, Ruofan Dong, et al.Molecular Medicine Reports|October 14, 2014
Restoration of microRNA‑218 increases cellular chemosensitivity to cervical cancer by inhibiting cell‑cycle progressionRuofan Dong, Haifeng Qiu, Guiqiang Du, et al.Nature Communications|October 26, 2021
Assessment of plum rain's impact on power system emissions in Yangtze-Huaihe River basin of ChinaGuangsheng Pan, Qinran Hu, Wei Gu, et al.Molecular Cancer Therapeutics|March 1, 2015
Frequent Loss of NISCH Promotes Tumor Proliferation and Invasion in Ovarian Cancer via Inhibiting the FAK Signal PathwayJing Li, Xiaoying He, Ruofan Dong, et al.The Journal of Obstetrics and Gynaecology Research|February 23, 2025
The efficacy of anti-angiogenic drugs in gastric-type endocervical adenocarcinoma: A retrospective studyJing Li, Dian Wang, Qing Duan, et al.Journal of Cancer Research and Clinical Oncology|January 13, 2012
Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasionJinjin Yu, Yuan Wang, Ruofan Dong, et al.Cancer Science|February 26, 2010
Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancerHaifeng Qiu, Jiezhi Zhu, Cunzhong Yuan, et al.Pageof 6